GLP1-RA wins expanded approval for diabetics with CKD

5 minute read


Semaglutide can now be prescribed to treat chronic kidney disease following strong trial results and TGA approval.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×